Literature DB >> 16167936

Selective feticide in complicated monochorionic twin pregnancies using ultrasound-guided bipolar cord coagulation.

Romaine Robyr1, Masami Yamamoto, Yves Ville.   

Abstract

OBJECTIVE: To review our experience with selective feticide in complicated monochorionic (MC) twin pregnancies, using ultrasound-guided cord coagulation with a bipolar forceps.
DESIGN: Retrospective analysis.
SETTING: All consecutive umbilical cord coagulations performed at our institution in the second trimester of pregnancy between November 1999 and 2003. POPULATION: Consecutive cases of complicated MC pregnancies with an indication for selective termination.
METHODS: Ultrasound-guided coagulation of the umbilical cord with a 2.5-mm bipolar forceps under local anaesthesia. MAIN OUTCOME MEASURES: Indications, gestational age at the procedure, perinatal outcome and neonatal follow up.
RESULTS: Forty-six patients with MC twin pregnancies underwent this procedure. Indications included twin reverse arterial perfusion sequence (n= 17), severe malformation in one twin (n= 7) and agonal presentation or cerebral anomalies of one twin in twin-to-twin transfusion syndrome (TTTS) after laser treatment or serial amniodrainage (n= 22). The procedure resulted in six intrauterine fetal demise (IUFD, 13%), with a rate of 41% and 3% when performed at 16-17 weeks or later, respectively (Fisher P= 0.002). Preterm rupture of the membranes (PROM) before 28 weeks and between 28 and 34 weeks occurred in 9% and 14% of the cases, respectively. All neonatal deaths (four) occurred in cases with PROM at 28 weeks or earlier. Paediatric follow up showed that all infants discharged alive but one were neurologically normal at 3-42 months, which corresponds to 70% of the 46 cases.
CONCLUSIONS: This technique is effective when the natural history is likely to severely affect the development of the normal co-twin. The overall intact survival rate was 70% and our results support justification of later surgery. Prematurity remains a significant complication of the procedure.

Entities:  

Mesh:

Year:  2005        PMID: 16167936     DOI: 10.1111/j.1471-0528.2005.00746.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  5 in total

1.  A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome.

Authors:  Timothy M Crombleholme; David Shera; Hanmin Lee; Mark Johnson; Mary D'Alton; Flint Porter; Jacquelyn Chyu; Richard Silver; Alfred Abuhamad; George Saade; Laurence Shields; David Kauffman; Joanne Stone; Craig T Albanese; Ray Bahado-Singh; Robert H Ball; Larissa Bilaniuk; Beverly Coleman; Diana Farmer; Vickie Feldstein; Michael R Harrison; Holly Hedrick; Jeffrey Livingston; Robert P Lorenz; David A Miller; Mary E Norton; William J Polzin; Julian N Robinson; Jack Rychik; Per L Sandberg; Istvan Seri; Erin Simon; Lynn L Simpson; Larisa Yedigarova; R Douglas Wilson; Bruce Young
Journal:  Am J Obstet Gynecol       Date:  2007-10       Impact factor: 8.661

Review 2.  Biomaterials in fetal surgery.

Authors:  Sally M Winkler; Michael R Harrison; Phillip B Messersmith
Journal:  Biomater Sci       Date:  2019-05-17       Impact factor: 6.843

3.  Uncommon complications of monochorionic twin pregnancies: Twin reversed arterial perfusion sequence.

Authors:  Katie E Fisher; Alec W Welsh; Amanda Henry
Journal:  Australas J Ultrasound Med       Date:  2016-09-26

4.  Selective termination of the fetus in multiple pregnancies using ultrasound-guided radiofrequency ablation.

Authors:  Nan Li; Jimei Sun; Jiayan Wang; Wei Jian; Jing Lu; Yonghui Miao; Yufan Li; Fei Chen; Dunjin Chen; Xiaoqing Ye; Min Chen
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-10       Impact factor: 3.007

5.  Conjoined twins in a monochorionic triplet pregnancy after in vitro fertilization: a case report.

Authors:  Marzieh Talebian; Fatemeh Rahimi-Sharbaf; Mahboobeh Shirazi; Batool Teimoori; Narges Izadi-Mood; Soheila Sarmadi
Journal:  Iran J Reprod Med       Date:  2015-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.